CIK 0001514946 · Non-accelerated filer<br>Smaller reporting company
AXIM BIOTECHNOLOGIES, INC.
Sign in to watch- Ticker
- AXIM
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 274092986
- Phone
- (212) 751-0001
- Business address
- 6191 CORNERSTONE COURT, E, SUITE 114, SAN DIEGO, CA, 92121
- Former names
- AXIM INTERNATIONAL INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-15 | HUEMOELLER JOHN WALTER II Chief Executive Officer | Grant or award · Convertible Note | +250,000 | $250,000.00 | $62.5B | 30,000,000 |
| 2024-03-15 | HUEMOELLER JOHN WALTER II Chief Executive Officer | Grant or award · Convertible Note | +250,000 | $250,000.00 | $62.5B | 42,500,000 |
| 2024-03-15 | Valencia Catalina 10% owner | Grant or award · Convertible Note | +7,837,500 | $156,750.00 | $1228.5B | 7,837,500 |
| 2024-03-15 | Schroeder Blake Director | Grant or award · Convertible Note | +35,000 | $35,000.00 | $1.2B | 4,500,000 |
| 2024-03-15 | Cunningham Robert L Director | Grant or award · Convertible Note | +35,000 | $35,000.00 | $1.2B | 4,500,000 |
| 2024-03-15 | Scott Timothy Richard Director | Grant or award · Convertible Note | +35,000 | $35,000.00 | $1.2B | 4,500,000 |
| 2024-03-15 | O'Rourke Peter Director | Grant or award · Convertible Note | +35,000 | $35,000.00 | $1.2B | 4,500,000 |
| 2024-03-15 | MALASEK ROBERT Chief Financial Officer | Grant or award · Convertible Note | +53,500 | $53,500.00 | $2.9B | 3,475,000 |
| 2024-03-15 | HUEMOELLER JOHN WALTER II Chief Executive Officer | Grant or award · Convertible Note | +1 | $250,000.00 | $250K | 42,500,000 |
| 2024-01-30 | Valencia Catalina President and Director | Purchase | +1,086,216 | 28,608,220 | ||
| 2022-09-23 | Schroeder Blake Director | Grant or award · Option | +1,000,000 | 1,000,000 | ||
| 2022-09-23 | MALASEK ROBERT Chief Financial Officer | Grant or award · Option | +500,000 | 800,000 | ||
| 2022-09-23 | Cunningham Robert L Director | Grant or award · Option | +1,000,000 | 1,500,000 | ||
| 2022-09-23 | Scott Timothy Richard Director | Grant or award · Option | +1,000,000 | 1,500,000 | ||
| 2022-09-23 | HUEMOELLER JOHN WALTER II Chief Executive Officer | Grant or award · Option | +5,000,000 | 8,000,000 | ||
| 2022-08-24 | Valencia Catalina 10% owner | Purchase | +3,861,004 | $0.03 | $100K | 23,661,004 |
| 2022-08-22 | Schroeder Blake Director | Conversion | +854,012 | $0.03 | $25K | 854,012 |
| 2022-02-10 | Schroeder Blake Director | Other acquisition · Convertible Note (Convertible into Common Stock) | +25,000 | $25,000.00 | $625.0M | 307,692 |
| 2021-05-06 | HUEMOELLER JOHN WALTER II Chief Executive Officer | Returned to the company · Option | −2,000,000 | 3,000,000 | ||
| 2020-12-10 | MALASEK ROBERT Chief Financial Officer | Grant or award · Option | +300,000 | 300,000 |
Page 1 of 2 · 35 trades